Transcriptional changes in response to ketamine ester-analogs SN 35210 and SN 35563 in the rat brain
Open Access
- 11 April 2019
- journal article
- research article
- Published by Springer Nature in BMC Genomics
- Vol. 20 (1) , 1-10
Abstract
Ketamine ester analogs, SN 35210 and SN 35563, demonstrate different pharmacological profiles to ketamine in animal models. Both confer hypnosis with predictably rapid offset yet, paradoxically, SN35563 induces a prolonged anti-nociceptive state. To explore underlying mechanisms, broad transcriptome changes were measured and compared across four relevant target regions of the rat brain. SN 35563 produced large-scale alteration of gene expression in the Basolateral Amygdala (BLA) and Paraventricular Nucleus of the Thalamus (PVT), in excess of 10x that induced by ketamine and SN 35210. A smaller and quantitatively similar number of gene changes were observed in the Insula (INS) and Nucleus Accumbens (ACB) for all three agents. In the BLA and PVT, SN 35563 caused enrichment for gene pathways related to the function and structure of glutamatergic synapses in respect to: release of neurotransmitter, configuration of postsynaptic AMPA receptors, and the underlying cytoskeletal scaffolding and alignment. The analgesic ketamine ester analog SN 35563 induces profound large-scale changes in gene expression in key pain-related brain regions reflecting its unique prolonged pharmacodynamic profile.Keywords
Funding Information
- Waikato Medical Research Foundation
- Medical Research Kirikiriroa Charitable Trust
This publication has 42 references indexed in Scilit:
- A Circadian Genomic Signature Common to Ketamine and Sleep Deprivation in the Anterior Cingulate CortexBiological Psychiatry, 2017
- Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant actionBMC Genomics, 2016
- Drug target prioritization by perturbed gene expression and network informationScientific Reports, 2015
- Development of Rapidly Metabolized and Ultra-Short-Acting Ketamine AnalogsAnesthesia & Analgesia, 2015
- Molecular recognition of ketamine by a subset of olfactory G protein–coupled receptorsScience Signaling, 2015
- Ketamine Pharmacology: An Update (Pharmacodynamics and Molecular Aspects, Recent Findings)CNS Neuroscience & Therapeutics, 2013
- The expression of genes involved in glucose metabolism is affected by N-methyl-D-aspartate receptor antagonism: A putative link between metabolism and an animal model of psychosisJournal of Neuroscience Research, 2012
- HCN1 Channel Subunits Are a Molecular Substrate for Hypnotic Actions of KetamineThe Journal of Neuroscience, 2009
- NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors—implications for models of schizophreniaMolecular Psychiatry, 2002
- Stereospecific Interaction of Ketamine with Nicotinic Acetylcholine Receptors in Human Sympathetic Ganglion-like SH-SY5Y CellsAnesthesiology, 2000